Graham Beaton,Fabio C. Tucci,Satheesh B. Ravula,Chandravadan R. Shah,Hiep Luu
申请号：
US16000283
公开号：
US10570103B2
申请日:
2018.06.05
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method for treating a lysophosphatidic acid-dependent disease or condition in a subject in need thereof is provided. The method includes administering to the subject a therapeutically effective amount of a heterocyclic compound. The heterocyclic compound is a lysophosphatidic acid receptor ligand. Lysophosphatidic acid-dependent diseases and conditions include diseases involving fibrosis, such as fibrosis of the heart, kidney, liver and lung, and scleroderma； inflammatory diseases such as diabetic nephropathy and inflammatory bowel disease； ocular diseases such as diseases involving retinal degeneration； nerve diseases such as pruritus and pain.
